Q-Line Biotech IPO Final Subscription Status

Final subscription data from BSE & NSE with category-wise breakdowns

📈 Building steadily
📈 GMP Today 🎟️ Allotment Status 📄 Full IPO Details Listed at NSE · Registrar: Purva Sharegistry (India) Pvt.Limited.
Listed SME
Price: ₹326 - ₹343 Lot: 800 Min: ₹2,74,400 Period: 21 May - 25 May
Subscribed
102.48x
Total Demand
₹14,618 Cr
Applications
2,35,591
Build by Day
4.11x → 9.86x → 102.48x

Subscription (Shares)

CategoryOfferedAppliedTimes
QIB 11,88,000 14,72,37,200 123.94
NII 8,91,600 13,04,65,600 146.33
bNII (>10 Lakh) 5,94,400 10,62,89,200 178.82
sNII (2-10 Lakh) 2,97,200 2,41,76,400 81.35
Retail 20,79,200 14,84,91,200 71.42
TOTAL 41,58,800 42,61,94,000 102.48

Application Breakup

CategoryReservedApplicationsTimes
NII 743 49,780 67.00
bNII (>10 Lakh) 495 31,162 62.95
sNII (2-10 Lakh) 248 18,618 75.07
Retail 2,599 1,85,614 71.42
TOTAL 4,085 2,35,591 57.67

Subscription (Crores)

CategoryOfferedDemandTimes
QIB 40.75 5,050.24 123.94
NII 30.58 4,474.97 146.33
bNII (>10 Lakh) 20.39 3,645.72 178.82
sNII (2-10 Lakh) 10.19 829.25 81.35
Retail 71.32 5,093.25 71.42
TOTAL 142.65 14,618.45 102.48

Day-wise Subscription

End-of-day subscription.

Each panel has its own scale.
Day QIB NII bNII sNII Retail Total
Day 1 21 May 4.15x 5.24x 5.84x 4.03x 3.61x 4.11x
Day 2 22 May 5.19x 15.96x 18.49x 10.90x 9.92x 9.86x
Day 3 25 May 123.94x 146.33x 178.82x 81.35x 71.42x 102.48x

Estimated Allotment Chance

Retail 1.6% (71.42x subscribed)
Low chance
S-HNI (2-10L) 1.2% (81.35x subscribed)
Low chance
B-HNI (>10L) 2.2% (178.82x subscribed)
Low chance
about 2 in 100 retail applicants are likely to get allotment.
Estimate from subscription data; the registrar's draw decides.

How Q-Line Biotech’s demand compares with recent SME IPOs

Final multiples against the 192 SME IPOs listed in the last 12 months.

CategoryQ-Line BiotechSME medianHigher than
Overall 102x 3.98x 77% of 192
QIB 124x 14.69x 82% of 163
NII (HNI) 146x 5.32x 78% of 192
Retail 71.42x 3.5x 76% of 192

Of the 44 recent SME IPOs that finished 100x or more subscribed, 91% opened above the issue price, with a median listing-day move of +42.9%. Q-Line Biotech itself listed at +31.8%.

Source: BSE and NSE. Not investment advice.

Q-Line Biotech IPO Subscription — Detailed Analysis

Where Q-Line Biotech Subscription Finished

Q-Line Biotech IPO was subscribed 102.48 times overall by the close of bidding — a heavily oversubscribed level that signals strong investor demand. A total of 2,35,591 applications were received.

Q-Line Biotech IPO Subscription — FAQs

Q-Line Biotech IPO was subscribed 102.48 times overall by the close of bidding.

Q-Line Biotech IPO was open for subscription from May 21, 2026 to May 25, 2026.

The price band for Q-Line Biotech IPO is ₹326 - ₹343 per share.

See also: reading the subscription table · allotment chances · allotment process

GMPUpdate